 Kami Schneider
Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Counseling | 6 | 2024 | 81 | 1.780 |
Why?
| | Genetic Testing | 6 | 2025 | 480 | 1.350 |
Why?
| | Neoplastic Syndromes, Hereditary | 7 | 2025 | 47 | 1.060 |
Why?
| | Genetic Predisposition to Disease | 12 | 2025 | 2355 | 0.980 |
Why?
| | Neurofibromatosis 1 | 2 | 2021 | 55 | 0.760 |
Why?
| | Early Detection of Cancer | 6 | 2025 | 482 | 0.750 |
Why?
| | Ribonuclease III | 5 | 2025 | 44 | 0.710 |
Why?
| | DEAD-box RNA Helicases | 5 | 2025 | 89 | 0.680 |
Why?
| | Anemia, Aplastic | 1 | 2021 | 42 | 0.680 |
Why?
| | Aniridia | 1 | 2020 | 5 | 0.660 |
Why?
| | PAX6 Transcription Factor | 1 | 2020 | 21 | 0.660 |
Why?
| | Codon, Nonsense | 1 | 2020 | 44 | 0.640 |
Why?
| | Eye Proteins | 1 | 2020 | 85 | 0.640 |
Why?
| | Myelodysplastic Syndromes | 1 | 2021 | 148 | 0.600 |
Why?
| | Wilms Tumor | 1 | 2020 | 88 | 0.600 |
Why?
| | Kidney Neoplasms | 2 | 2021 | 416 | 0.600 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2021 | 686 | 0.450 |
Why?
| | Biomarkers, Tumor | 1 | 2021 | 1321 | 0.400 |
Why?
| | Neoplasms | 3 | 2024 | 2897 | 0.390 |
Why?
| | Phenotype | 1 | 2021 | 3157 | 0.360 |
Why?
| | Hamartoma Syndrome, Multiple | 2 | 2025 | 16 | 0.350 |
Why?
| | Counselors | 2 | 2024 | 14 | 0.340 |
Why?
| | Mutation | 3 | 2025 | 4093 | 0.340 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2024 | 71 | 0.330 |
Why?
| | Child | 16 | 2025 | 22680 | 0.290 |
Why?
| | Central Nervous System Neoplasms | 2 | 2023 | 177 | 0.280 |
Why?
| | DNA Mismatch Repair | 3 | 2024 | 53 | 0.260 |
Why?
| | Fellowships and Scholarships | 1 | 2011 | 355 | 0.250 |
Why?
| | Societies, Medical | 1 | 2011 | 898 | 0.250 |
Why?
| | Germ-Line Mutation | 3 | 2025 | 176 | 0.240 |
Why?
| | Carney Complex | 1 | 2025 | 1 | 0.230 |
Why?
| | Jaw Neoplasms | 1 | 2025 | 3 | 0.230 |
Why?
| | Nose Diseases | 1 | 2025 | 17 | 0.230 |
Why?
| | Hyperparathyroidism | 1 | 2025 | 11 | 0.230 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 2025 | 5 | 0.230 |
Why?
| | Hamartoma | 1 | 2025 | 29 | 0.230 |
Why?
| | von Hippel-Lindau Disease | 1 | 2025 | 12 | 0.230 |
Why?
| | Leiomyomatosis | 1 | 2025 | 4 | 0.220 |
Why?
| | DNA Repair-Deficiency Disorders | 1 | 2024 | 5 | 0.210 |
Why?
| | Pheochromocytoma | 1 | 2025 | 67 | 0.210 |
Why?
| | Paraganglioma | 1 | 2025 | 64 | 0.210 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2025 | 98 | 0.210 |
Why?
| | Tuberous Sclerosis | 1 | 2025 | 56 | 0.210 |
Why?
| | Skin Neoplasms | 2 | 2025 | 850 | 0.210 |
Why?
| | Rare Diseases | 1 | 2025 | 116 | 0.210 |
Why?
| | Students | 1 | 2009 | 658 | 0.200 |
Why?
| | Colorectal Neoplasms | 2 | 2022 | 866 | 0.200 |
Why?
| | Prognosis | 3 | 2021 | 4323 | 0.200 |
Why?
| | PTEN Phosphohydrolase | 1 | 2025 | 164 | 0.200 |
Why?
| | Peutz-Jeghers Syndrome | 2 | 2024 | 10 | 0.180 |
Why?
| | Brain Neoplasms | 2 | 2022 | 1329 | 0.180 |
Why?
| | Adenomatous Polyposis Coli | 2 | 2024 | 40 | 0.180 |
Why?
| | Humans | 26 | 2025 | 145491 | 0.180 |
Why?
| | DNA Repair Enzymes | 1 | 2021 | 29 | 0.170 |
Why?
| | Pulmonary Blastoma | 1 | 2021 | 8 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2021 | 13 | 0.170 |
Why?
| | Child, Preschool | 5 | 2021 | 11837 | 0.160 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1585 | 0.150 |
Why?
| | Adolescent | 9 | 2025 | 22485 | 0.150 |
Why?
| | Codes of Ethics | 1 | 2017 | 16 | 0.130 |
Why?
| | Ethics, Professional | 1 | 2017 | 14 | 0.130 |
Why?
| | Retinoblastoma Binding Proteins | 1 | 2017 | 6 | 0.130 |
Why?
| | Optic Nerve Glioma | 1 | 2017 | 1 | 0.130 |
Why?
| | Pinealoma | 1 | 2017 | 10 | 0.130 |
Why?
| | Neurofibromatoses | 1 | 2017 | 8 | 0.130 |
Why?
| | Neurilemmoma | 1 | 2017 | 25 | 0.130 |
Why?
| | Retinoblastoma | 1 | 2017 | 42 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2023 | 3619 | 0.120 |
Why?
| | Genetic Association Studies | 1 | 2018 | 369 | 0.120 |
Why?
| | Neuroblastoma | 1 | 2017 | 174 | 0.120 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 191 | 0.110 |
Why?
| | Follow-Up Studies | 2 | 2021 | 5426 | 0.110 |
Why?
| | Infant | 4 | 2023 | 10064 | 0.110 |
Why?
| | Microsatellite Instability | 2 | 2024 | 55 | 0.100 |
Why?
| | Male | 6 | 2021 | 72817 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2025 | 17269 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2021 | 2664 | 0.060 |
Why?
| | Universities | 1 | 2009 | 455 | 0.060 |
Why?
| | Female | 6 | 2025 | 78763 | 0.060 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2025 | 18 | 0.060 |
Why?
| | Nasal Cavity | 1 | 2025 | 62 | 0.060 |
Why?
| | Succinate Dehydrogenase | 1 | 2025 | 66 | 0.060 |
Why?
| | Uterine Neoplasms | 1 | 2025 | 96 | 0.050 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2024 | 40 | 0.050 |
Why?
| | United States | 3 | 2021 | 16115 | 0.050 |
Why?
| | Germ Cells | 1 | 2022 | 65 | 0.050 |
Why?
| | DNA Replication | 1 | 2024 | 252 | 0.050 |
Why?
| | Microsatellite Repeats | 1 | 2022 | 156 | 0.040 |
Why?
| | Risk Assessment | 2 | 2024 | 3759 | 0.040 |
Why?
| | Cause of Death | 1 | 2023 | 469 | 0.040 |
Why?
| | Kidney Diseases, Cystic | 1 | 2021 | 24 | 0.040 |
Why?
| | Pneumothorax | 1 | 2021 | 52 | 0.040 |
Why?
| | Syndrome | 1 | 2021 | 380 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 8039 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2021 | 320 | 0.040 |
Why?
| | Pedigree | 1 | 2021 | 515 | 0.040 |
Why?
| | Protein Domains | 1 | 2021 | 314 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2020 | 221 | 0.030 |
Why?
| | Penetrance | 1 | 2018 | 30 | 0.030 |
Why?
| | Inheritance Patterns | 1 | 2018 | 44 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 5891 | 0.030 |
Why?
| | Societies | 1 | 2017 | 40 | 0.030 |
Why?
| | Population Surveillance | 1 | 2021 | 485 | 0.030 |
Why?
| | Public Health Surveillance | 1 | 2018 | 83 | 0.030 |
Why?
| | Counseling | 1 | 2020 | 405 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 834 | 0.030 |
Why?
| | Adult | 3 | 2021 | 40707 | 0.030 |
Why?
| | Survival Rate | 1 | 2021 | 2093 | 0.030 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 196 | 0.030 |
Why?
| | Young Adult | 2 | 2024 | 14192 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2017 | 230 | 0.030 |
Why?
| | Neuroimaging | 1 | 2017 | 293 | 0.030 |
Why?
| | Global Health | 1 | 2018 | 404 | 0.030 |
Why?
| | Disease Management | 1 | 2018 | 654 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 525 | 0.020 |
Why?
| | Genotype | 1 | 2018 | 1853 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2017 | 693 | 0.020 |
Why?
| | Parents | 1 | 2020 | 1404 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2855 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2021 | 2772 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1855 | 0.020 |
Why?
| | Mass Screening | 1 | 2018 | 1358 | 0.020 |
Why?
| | Transcription Factors | 1 | 2017 | 1733 | 0.020 |
Why?
| | Pediatrics | 1 | 2017 | 1121 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3897 | 0.010 |
Why?
|
|
Schneider's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|